Epic Sciences lands $52 mln Series E
San Diego-based Epic Sciences Inc, a developer of solutions to personalize and advance cancer treatment and management, has secured $52 million in Series E funding. Blue Ox Healthcare Partners LLC led the round.
12 September 2018•1 min read
